BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation

NASDAQ:BWAY • US10501L1061

Current stock price

13.86 USD
+0.36 (+2.67%)
At close:
13.86 USD
0 (0%)
After Hours:

This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BWAY Profitability Analysis

1.1 Basic Checks

  • BWAY had positive earnings in the past year.
  • In the past year BWAY had a positive cash flow from operations.
  • In the past 5 years BWAY reported 4 times negative net income.
  • In multiple years BWAY reported negative operating cash flow during the last 5 years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • With an excellent Return On Assets value of 5.53%, BWAY belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
  • BWAY's Return On Equity of 8.92% is amongst the best of the industry. BWAY outperforms 81.48% of its industry peers.
  • With a decent Return On Invested Capital value of 2.75%, BWAY is doing good in the industry, outperforming 70.90% of the companies in the same industry.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of BWAY (12.73%) is better than 86.77% of its industry peers.
  • BWAY's Operating Margin of 5.78% is fine compared to the rest of the industry. BWAY outperforms 71.43% of its industry peers.
  • BWAY has a better Gross Margin (74.92%) than 85.19% of its industry peers.
  • BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. BWAY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
  • There is no outstanding debt for BWAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • BWAY has an Altman-Z score of 3.73. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
  • BWAY's Altman-Z score of 3.73 is fine compared to the rest of the industry. BWAY outperforms 72.49% of its industry peers.
  • The Debt to FCF ratio of BWAY is 0.37, which is an excellent value as it means it would take BWAY, only 0.37 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BWAY (0.37) is better than 92.06% of its industry peers.
  • BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.08, BWAY is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 3.73
ROIC/WACC0.32
WACC8.47%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 3.19 indicates that BWAY has no problem at all paying its short term obligations.
  • BWAY has a Current ratio of 3.19. This is comparable to the rest of the industry: BWAY outperforms 57.14% of its industry peers.
  • BWAY has a Quick Ratio of 3.02. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
  • BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. BWAY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 117.91% over the past year.
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%

3.2 Future

  • Based on estimates for the next years, BWAY will show a very strong growth in Earnings Per Share. The EPS will grow by 29.61% on average per year.
  • Based on estimates for the next years, BWAY will show a very strong growth in Revenue. The Revenue will grow by 23.85% on average per year.
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.37%
Revenue Next 2Y23.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

7

4. BWAY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.74, the valuation of BWAY can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 92.59% of the companies listed in the same industry.
  • BWAY is valuated cheaply when we compare the Price/Earnings ratio to 25.61, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 11.13, the valuation of BWAY can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, BWAY is valued cheaply inside the industry as 92.06% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of BWAY to the average of the S&P500 Index (22.79), we can say BWAY is valued rather cheaply.
Industry RankSector Rank
PE 10.74
Fwd PE 11.13
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BWAY indicates a somewhat cheap valuation: BWAY is cheaper than 67.72% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BWAY is valued cheaper than 96.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.82
EV/EBITDA 42.03
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • BWAY's earnings are expected to grow with 29.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.61%
EPS Next 3YN/A

0

5. BWAY Dividend Analysis

5.1 Amount

  • No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield 0%

BWAY Fundamentals: All Metrics, Ratios and Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (3/25/2026, 8:13:41 PM)

After market: 13.86 0 (0%)

13.86

+0.36 (+2.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners5.36%
Inst Owner Change10.06%
Ins Owners15.48%
Ins Owner Change0%
Market Cap271.82M
Revenue(TTM)N/A
Net Income(TTM)6.25M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)0%
PT rev (3m)3.66%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-6.51%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)5.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.87%
Valuation
Industry RankSector Rank
PE 10.74
Fwd PE 11.13
P/S 5.54
P/FCF 14.82
P/OCF 12.2
P/B 3.88
P/tB 3.88
EV/EBITDA 42.03
EPS(TTM)1.29
EY9.31%
EPS(NY)1.25
Fwd EY8.99%
FCF(TTM)0.94
FCFY6.75%
OCF(TTM)1.14
OCFY8.19%
SpS2.5
BVpS3.57
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.18
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 3.73
F-Score5
WACC8.47%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
Revenue Next Year23.37%
Revenue Next 2Y23.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY Fundamental Analysis FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for BWAY stock?

The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to decline by -3.28% in the next year.